Varlitinib is an oral, selective, reversible, small molecule tyrosine kinase inhibitor of both ErbB-2 (Her-2/neu) and EGFR. Over-expression of ErbB-2 and EGFR receptors in tumors is predictive of poor prognosis in cancer patients. Varlitinib has shown significant anti-tumor activity in preclinical models of human breast, lung, and epidermal carcinoma tumors.
Synonyms: DB12723 Varlitinib
This is just here as a test because I lose it
Term information
database
cross reference
- ChEMBL:CHEMBL2103842
- BindingDB:50205268
- ChemSpider:25027380
- CAS:845272-21-1
- PubChem Substance:347827751
- PubChem Compound:42642648
hasDbXref
ChemSpider:25027380
PubChem Substance:347827751
PubChem Compound:42642648
ChEMBL:CHEMBL2103842
CAS:845272-21-1
BindingDB:50205268